ロード中...
Measuring ACPA in the general population or primary care: is it useful?
Rheumatoid arthritis (RA) is associated with a significant disease burden and high costs for society. Because the disease has identifiable preclinical stages, screening and prevention have become a possibility in RA. Anticitrullinated peptide antibodies (ACPAs) are arguably the most likely candidate...
保存先:
| 出版年: | RMD Open |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046970/ https://ncbi.nlm.nih.gov/pubmed/32079664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-001085 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|